cardiac monitoring

Research Takeaway: I received heart-damaging treatment. How often do I need an echocardiogram?

Recent research underscores the importance of monitoring heart health before and after chemotherapy, especially for patients undergoing heart-damaging (cardiotoxic) treatments such as anthracyclines or trastuzumab. A 2025 study followed over 800 breast cancer survivors for an average of eight years. The researchers found that cardiac dysfunction increased over time, from 1.8% at two years after treatment to 15.3% at 15 years.